Insider Trading & Ownership - Tessier-Lavigne Marc

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Tessier-Lavigne Marc
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-23
Sale
2022-11-28
7:30 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$30.48$609,6002,107,225
(Indirect
Direct)
View
2022-11-01
Sale
2022-11-03
5:37 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$30.27$605,4632,127,225
(Indirect
Direct)
View
2022-09-29
Sale
2022-10-03
4:05 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
10,838$702.24$7,610,84412,921
(Direct)
View
2022-09-28
Sale
2022-09-30
4:50 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$30.82$616,3042,147,225
(Indirect
Direct)
View
2022-08-23
Sale
2022-08-25
6:11 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$31.61$632,2822,167,225
(Indirect
Direct)
View
2022-07-25
Sale
2022-07-27
6:49 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$35.61$712,1102,187,225
(Indirect
Direct)
View
2022-03-23
Sale(A)
2022-06-28
3:07 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$33.83$676,5832,261,239
(Indirect
Direct)
View
2022-03-23
Sale
2022-03-25
5:57 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
20,000$33.83$676,5832,261,239
(Indirect
Direct)
View
2022-03-21
Sale
2022-03-23
4:01 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
7,439$690$5,132,9102,269
(Direct)
View
2022-03-16
Sale
2022-03-18
4:05 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
12,191$678.21$8,268,0752,269
(Direct)
View
2021-12-28
Sale
2021-12-30
9:59 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
63,131$44.43$2,805,1972,323,218
(Indirect
Direct)
View
2021-12-09
Sale
2021-12-10
5:41 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
3,784$665$2,516,3602,078
(Direct)
View
2021-09-13
Sale
2021-09-15
4:02 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
12,750$641.71$8,181,82714,828
(Direct)
View
2021-06-07
Sale
2021-06-08
5:10 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
94,378$70.35$6,639,5232,552,232
(Direct)
View
2021-05-21
Sale
2021-05-24
8:05 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
46,763$60.11$2,811,0482,542,296
(Direct)
View
2021-05-03
Sale
2021-05-05
4:14 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
3,237$60.11$194,5892,589,059
(Direct)
View
2021-04-01
Sale
2021-04-05
4:10 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
50,000$56.62$2,831,0712,592,296
(Direct)
View
2021-03-01
Sale
2021-03-03
4:20 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
100,000$66.22$6,622,2072,642,296
(Direct)
View
2020-06-16
Sale
2020-06-18
9:41 pm
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
400,000$26.1$10,440,0002,739,043
(Direct)
View
2020-05-06
Sale
2020-05-08
4:03 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
15,000$563.97$8,459,4961,830
(Direct)
View
2020-02-13
Sale
2020-02-14
4:10 pm
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
14,279$400.01$5,711,7111,830
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-01
Option Award
2023-06-05
6:06 pm
N/A
2033-06-01
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
16,865$02,124,090
(Direct)
View
2023-01-03
Option Award
2023-01-05
4:16 pm
N/A
2033-01-03
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
2,094$04,363
(Direct)
View
2023-01-03
Option Award
2023-01-05
4:16 pm
N/A
2033-01-03
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
2,094$04,363
(Direct)
View
2022-09-29
Exercise
2022-10-03
4:05 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
10,838$413.3312,921
(Direct)
View
2022-09-29
Exercise
2022-10-03
4:05 pm
N/A
2025-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
10,838$012,921
(Direct)
View
2022-06-24
Disposition
2022-06-27
8:54 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
39,984$30.532,207,225
(Direct)
View
2022-06-24
Disposition
2022-06-27
8:54 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
6,766$31.082,207,225
(Direct)
View
2022-06-23
Disposition
2022-06-27
8:54 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
13,250$31.12,207,225
(Direct)
View
2022-06-02
Option Award
2022-06-06
8:09 pm
N/A
2032-06-02
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
23,945$02,285,184
(Direct)
View
2022-03-21
Exercise
2022-03-23
4:01 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
7,439$380.952,269
(Direct)
View
2022-03-21
Exercise
2022-03-23
4:01 pm
N/A
2028-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
7,439$02,269
(Direct)
View
2022-03-16
Exercise
2022-03-18
4:05 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
4,361$374.122,269
(Direct)
View
2022-03-17
Exercise
2022-03-18
4:05 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
7,830$376.692,269
(Direct)
View
2022-03-16
Exercise
2022-03-18
4:05 pm
N/A
2030-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
12,191$02,269
(Direct)
View
2021-12-13
Ownership
2022-02-17
8:25 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
200,000$02,281,239
(Direct)
View

Ownership
2022-02-17
8:25 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
0$02,281,239
(Indirect)
View
2022-01-03
Option Award
2022-01-05
4:23 pm
N/A
2032-01-03
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
2,898$04,976
(Direct)
View
2021-10-04
Gift
2021-12-30
9:59 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
400,000$02,323,218
(Direct)
View
2021-12-09
Exercise
2021-12-10
5:41 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
3,784$371.42,078
(Direct)
View
2021-12-09
Exercise
2021-12-10
5:41 pm
N/A
2029-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
3,784$02,078
(Direct)
View
2021-09-13
Exercise
2021-09-15
4:02 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
4,250$273.6714,828
(Direct)
View
2021-09-13
Exercise
2021-09-15
4:02 pm
N/A
2024-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
12,750$014,828
(Direct)
View
2021-06-07
Exercise
2021-06-08
5:10 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
27,830$18.922,552,232
(Direct)
View
2021-06-07
Exercise
2021-06-08
5:10 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
27,245$19.52,552,232
(Direct)
View
2021-06-07
Exercise
2021-06-08
5:10 pm
N/A
N/A
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
39,303$182,552,232
(Direct)
View
2021-06-07
Exercise
2021-06-08
5:10 pm
N/A
2027-12-07
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
94,378$02,552,232
(Direct)
View
2021-06-02
Option Award
2021-06-04
6:37 pm
N/A
2031-06-02
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
8,296$02,550,592
(Direct)
View
2021-01-04
Option Award
2021-01-05
4:11 pm
N/A
2031-01-04
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
3,861$05,691
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:00 pm
N/A
2030-06-02
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
18,436$018,436
(Direct)
View
2020-05-06
Exercise
2020-05-08
4:03 pm
N/A
2023-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
15,000$01,830
(Direct)
View
2020-05-06
Exercise
2020-05-08
4:03 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
15,000$177.821,830
(Direct)
View
2020-02-13
Exercise
2020-02-14
4:10 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
5,000$57.111,830
(Direct)
View
2020-02-13
Exercise
2020-02-14
4:10 pm
N/A
N/A
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
9,279$50.911,830
(Direct)
View
2020-02-13
Exercise
2020-02-14
4:10 pm
N/A
2021-11-18
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
14,279$01,830
(Direct)
View
2020-01-02
Option Award
2020-01-06
4:07 pm
N/A
2030-01-02
REGENERON PHARMACEUTICALS INC.REGNTessier-Lavigne Marc
Director
4,681$06,191
(Direct)
View
2019-05-30
Option Award
2019-05-31
6:38 pm
N/A
2029-05-29
Denali Therapeutics Inc.DNLITessier-Lavigne Marc
Director
27,245$027,245
(Direct)
View
(A) Indicate amendment filing.